SGP 10-Q: SEC filing

SpyGlass Pharma, Inc.

Filed with the SEC on · accession 0001778922-26-000056

SGP filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -4.7% by the first close after the filing.

Summary of the filing

SpyGlass Pharma, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including an IPO completed in February 2026 and ongoing research and development expenses.

Key details

FilerSpyGlass Pharma, Inc.

How SGP stock reacted

Close before

$34.97

Nov 11, 2026

First close after

-4.72%

$33.32

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for SGP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SGP?

Click here

Frequently asked questions

What did SGP file with the SEC on Nov 12, 2026?

SGP filed a 10-Q (SEC filing). SpyGlass Pharma, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including an IPO completed in February 2026 and ongoing research and development expenses.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did SGP stock react to this filing?

SGP closed at $34.97 before the filing and $33.32 on Nov 12, 2026 (-4.72%).

Other SGP SEC filings

Get alerts when SGP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days